Activity by Duska Anastasijevic
Rochester, Minn.Â â€” Mayo Clinic will host the Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) symposium Oct. 9-10, 2015. The symposium aims to further the collaborative approach to initiate and accelerate discovery in brain science. Government, industry and academic leaders and researchers from across the globe will convene in Rochester to further their work in neuroscience research and therapies. Walter Koroshetz, M.D., the director of the National Institute of Neurological Disorders and Stroke, will be the keynote speaker.
â€śBy bringing together stakeholders from across the range of groups involved in the BRAIN Initiative, we hope to highlight the dual promises of the BRAIN Initiative: to drive public/private collaboration toward developing revolutionary tools to aid the basic understanding of the brain and to quickly translate these discoveries into therapies,â€ť says Kendall Lee, M.D., Ph.D., Mayo Clinic neurosurgeon, who leads the Mayo Clinic Neural Engineering Laboratory, a team of more than 30 neurosurgeons, neurobiologists, engineers, imaging scientists and support staff. This team and the collaborators from the University of Texas in El Paso and Hanyang University in Korea won the BRAIN Initiative award to develop deep brain stimulation technology to detect the release of neurotransmitters in the living brain and modulate brain activity.
MEDIA CONTACT: Duska Anastasijevic, Mayo Clinic Public Affairs, 507-284-5005, email@example.com [...]
ROCHESTER, Minn. â€” Researchers at Mayo Clinic were awarded a $6.8 million, five-year federal grant from the National Institutes of Health to develop intelligent devices to track and treat abnormal brain activity in people with epilepsy. The grant, part of a presidential initiative aimed at revolutionizing the understanding of the human brain, is called Brain Research Through Advancing Innovative Neurotechnologies or the BRAIN Initiative.
Epilepsy affects 60 million people worldwide and 3 million in the U.S. Approximately one-third of people with epilepsy will continue having seizures, despite taking daily medications. Seizures, the hallmark of epilepsy, are sudden events that strike patients without warning. The goal of the research is to develop an implantable device that can record brain activity continuously to forecast upcoming seizures and stimulate multiple brain regions in real time to prevent seizures before they ever occur.
Journalists: Sound bites with Dr. Worrell are available in the downloads.
MEDIA CONTACT: Duska Anastasijevic, Mayo Clinic Public Affairs, 507-284-5005, email: firstname.lastname@example.org
ROCHESTER, Minn. â€” While autoimmune cerebellar ataxia (a loss of muscle control coordination) can lead to severe disability with some patients becoming wheelchair-bound, there are factors that may help predict better immunotherapy response, according to the Mayo Clinic study published by JAMA Neurology.
Autoimmune cerebellar ataxia in adults, which usually comes on rapidly and progresses quickly, can be divided into disorders that are paraneoplastic (triggered by cancer in the body) or nonparaneoplastic (autoimmune disorders of the central nervous system unrelated to cancer). The disabling neurological effects, which can include speech, eye movement and balance, can cause unsteady walk and difficulties when swallowing. Little has been published regarding treatment responses and neurologic outcomes among patients with autoimmune cerebellar ataxia. However, at least 17 autoantibodies have been reported as causally linked to autoimmune cerebellar ataxia.
â€śHistorically, we found cerebellar ataxia to be a hopeless disease,â€ť says Andrew McKeon, M.B., B.Ch., M.D., a neurologist on Mayo Clinicâ€™s Rochester campus and lead author of the study. â€śAlthough usually severe, treatment responses can be gratifying, particularly in patients with nonparaneoplastic disorders.â€ť
Journalists: Sound bites with Dr. McKeon are available in the downloads.
MEDIA CONTACT: Duska Anastasijevic, Mayo Clinic Public Affairs, 507-284-5005, email@example.com
ROCHESTER, Minn.Â â€” Future improvements in the U.S health care system will come from individuals, not large institutions or systems, say the organizers of Mayo Clinic Transform 2015, a three-day conference that will take place Sept. 30â€“Oct. 2 at the Mayo Civic Center in Rochester andÂ showcase individuals who are taking charge of their health, and spark positive changes in the health care system.
People Power Health is the theme of the Transform 2015 conference. â€śThis theme underscores the momentum underway around the world,â€ť says Barbara Spurrier, administrative director of Mayo Clinic Center for Innovation, which is the host of the conference. â€śWe are seeing the center of gravity shift away from traditional hospitals and health careÂ -Â to the people.â€ť
Now in its eighth year, Transform features a program of innovators in health and health care from throughout the country.
For inquires and media passes, contact Cathryn Kennedy at firstname.lastname@example.org or 612-309-3951 or 507-284-5005.
American and Chinese adults with Type 2 diabetes are at similar risk for memory impairment, Mayo Clinic and Shanghai researchers report
Rochester, Minn. â€“ Diabetes is a known risk factor for cognitive decline and dementia, age-related conditions that affect memory and thinking skills. However, little is known about how the diabetes-cognitive decline link compares across cultures.
Scientists from Mayo Clinic and Huashan Hospital in Shanghai explored the association between Type 2 diabetes and cognitive impairment to find out if the relationship varies in different populations. Study participants had not been diagnosed with memory-related diseases, such as vascular dementia or Alzheimer's dementia.
For the study, the researchers evaluated data from two large, ongoing, population-based studies: the Shanghai Aging Study (SAS) and the Mayo Clinic Study of Aging (MCSA). Both use similar designs and methodologies. For example, both studies recruit participants from a defined population, include an on-site, in-person evaluation, use similar or comparable tests of cognition, and include participants over age 50. The SAS uses neuropsychological tests adapted from Western tests to harmonize with Chinese culture.
Rochester, Minn. â€“ Terrence L. Cascino, M.D., of Mayo Clinic in Rochester was elected the president of the American Academy of Neurology (AAN), the worldâ€™s largest professional association of neurologists and neuroscientists with 28,000 members.
Dr. Cascino, AANâ€™s 34th president, succeeds Timothy A. Pedley, MD, professor of neurology at the Columbia University Medical Center.
â€śThis is an opportunity of a lifetime to serve our 28,000 members of AAN with unparalleled resources to help them provide the highest quality patient-centered neurologic care for the one in six people worldwide who have a brain disease, such as Alzheimerâ€™s disease, stroke, epilepsy, autism, and Parkinsonâ€™s diseaseâ€ť said Dr. Cascino. â€śI am privileged to follow a long line of distinguished neurologists committed to expanding the reach of the AAN, demonstrating the value of neurologists, enhancing their career satisfaction and most importantly, being indispensable to our members.â€ť
More information about the leadership announcement can be found in the AAN news release here.
ROCHESTER, Minn â€“ Researchers at Mayo Clinic developed a new scoring system to help determine which elderly people may be at a higher risk of developing the memory and thinking problems that can lead to dementia. Â The study is published in the March 18, 2015, online issue of NeurologyÂ®, the medical journal of the American Academy of Neurology.
â€śOur goal is to identify people who are at the highest risk for dementia as early as possibleâ€ť said study author Ronald Petersen, M.D., Ph.D., Chester and Debbie Cadieux Director of the Mayo Clinic Alzheimer's Disease Research Center, Cora Kanow Professor of Alzheimerâ€™s Disease Research and a member of the American Academy of Neurology.
MEDIA CONTACT:Â Duska Anastasijevic, Mayo Clinic Public Affairs, 507-284-5005, email@example.com
Journalists: Sound bites with Dr. Petersen are available in the downloads.
Projects will help advance research through collaborations and development of novel strategies for frontotemporal dementia
Rochester, Minn. â€”Â Mayo Clinic has been awarded two grants for large, five-year projects on frontotemporal dementia (FTD), characterized by degeneration of the frontal and temporal lobes of the brain. While rare, it may strike people in their twenties, even in their teens.
Duska Anastasijevic, Mayo Clinic Public Affairs, 507-284-5005, Email: firstname.lastname@example.org
Journalists: Sound bites are available in the downloads. [...]